This paper is based on the author’s 20+ years of experience treating patients with congestive heart failure (CHF) as a cardiologist. In the 20+ years, 64 patients were treated, including both with reduced and preserved left ventricular function. Most patients had a 4 - 5 days hospitalization in their first admission with one readmission (1.6%) over seven years. This paper will help us understand the physiology and pathophysiology of congestive heart failure, especially how to use beta blockers and diuretics. It will shorten the length of hospitalization and lower the readmission rate and cost of CHF treatment. This paper will help us to open another research direction for CHF.
References
[1]
Heidenreich, P.A., Fonarow, G.C., Opsha, Y., Sandhu, A.T., Sweitzer, N.K., Warraich, H.J., et al. (2022) Economic Issues in Heart Failure in the United States. Journal of Cardiac Failure, 28, 453-466. https://doi.org/10.1016/j.cardfail.2021.12.017
[2]
Virani, S.S., Alonso, A., Benjamin, E.J., Bittencourt, M.S., Callaway, C.W., Carson, A.P., et al. (2020) Heart Disease and Stroke Statistics—2020 Update: A Report from the American Heart Association. Circulation, 141, e139–e596. https://doi.org/10.1161/cir.0000000000000757
[3]
Heidenreich, P.A., Albert, N.M., Allen, L.A., Bluemke, D.A., Butler, J., Fonarow, G.C., et al. (2013) Forecasting the Impact of Heart Failure in the United States. Circulation: Heart Failure, 6, 606-619. https://doi.org/10.1161/hhf.0b013e318291329a
[4]
Yancy, C.W., Jessup, M., Bozkurt, B., Butler, J., Casey, D.E., Drazner, M.H., et al. (2013) 2013 ACCF/AHA Guideline for the Management of Heart Failure. Circulation, 128, e240-327. https://doi.org/10.1161/cir.0b013e31829e8776
[5]
Heidenreich, P.A., et al. (2022) 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 145, e895-e1032. https://doi.org/10.1161/CIR.0000000000001073
[6]
Waagstein, F. and Rutherford, J.D. (2017) The Evolution of the Use of Β-Blockers to Treat Heart Failure. Circulation, 136, 889-893. https://doi.org/10.1161/circulationaha.117.029934
